Danielle Ní Chróinín1, Chantelle Ní Chróinín2, Alexander Beveridge1. 1. Department of Geriatric Medicine, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney, New South Wales 2010, Australia. 2. Mater Misericordiae University Hospital, Dublin, Ireland.
Abstract
BACKGROUND: deprescribing habits among physicians managing older, frailer, cognitively impaired patients have not been well investigated. METHODS: an anonymised electronic survey was disseminated to all members of an international geriatric society/local advanced trainee network (N = 930). This comprised a Likert-scale analysis of factors influencing desprescribing, and five case vignettes, detailing a patient with progressive cognitive impairment and dependency, on a background of ischaemic heart disease and hypertension. RESULTS: among 134 respondents (response rate 14.4%), 47.4% were female, 48.9% aged 36-50 years and 84.1% specialists (15.9% trainees). Respondents commonly rated limited life expectancy (96.2%) and cognitive impairment (84.1%) as very/extremely important to deprescribing practices. On multivariable analysis, older respondents less commonly rated functional dependency (odds ratio [OR] 0.22 per change in age category; P < 0.001) and limited life expectancy (OR 0.09, P = 0.04) important when deprescribing, while female participants (OR 3.03, P < 0.001) and trainees (versus specialists OR 14.29, P < 0.001) more often rated adherence to evidence-based guidelines important. As vignettes described increasing dependency and cognitive impairment, physicians were more likely to stop donepezil, aspirin, atorvastatin and antihypertensives (all P < 0.001 for trend). Aspirin (93.6%) and ramipril (94.1%) were most commonly deprescribed. Commonest reasons cited for deprescribing medications were 'dementia severity', followed by pill burden. CONCLUSION: in this exploratory analysis, geriatricians rated limited life expectancy and cognitive impairment very important in driving deprescribing practices. Geriatricians more often deprescribed multiple medications in the setting of advancing dependency and cognitive impairment, driven by dementia severity and pill burden concerns. Physician characteristics also influence deprescribing practices. Further exploration of factors influencing deprescribing patterns, and patient outcomes, is needed.
BACKGROUND: deprescribing habits among physicians managing older, frailer, cognitively impairedpatients have not been well investigated. METHODS: an anonymised electronic survey was disseminated to all members of an international geriatric society/local advanced trainee network (N = 930). This comprised a Likert-scale analysis of factors influencing desprescribing, and five case vignettes, detailing a patient with progressive cognitive impairment and dependency, on a background of ischaemic heart disease and hypertension. RESULTS: among 134 respondents (response rate 14.4%), 47.4% were female, 48.9% aged 36-50 years and 84.1% specialists (15.9% trainees). Respondents commonly rated limited life expectancy (96.2%) and cognitive impairment (84.1%) as very/extremely important to deprescribing practices. On multivariable analysis, older respondents less commonly rated functional dependency (odds ratio [OR] 0.22 per change in age category; P < 0.001) and limited life expectancy (OR 0.09, P = 0.04) important when deprescribing, while female participants (OR 3.03, P < 0.001) and trainees (versus specialists OR 14.29, P < 0.001) more often rated adherence to evidence-based guidelines important. As vignettes described increasing dependency and cognitive impairment, physicians were more likely to stop donepezil, aspirin, atorvastatin and antihypertensives (all P < 0.001 for trend). Aspirin (93.6%) and ramipril (94.1%) were most commonly deprescribed. Commonest reasons cited for deprescribing medications were 'dementia severity', followed by pill burden. CONCLUSION: in this exploratory analysis, geriatricians rated limited life expectancy and cognitive impairment very important in driving deprescribing practices. Geriatricians more often deprescribed multiple medications in the setting of advancing dependency and cognitive impairment, driven by dementia severity and pill burden concerns. Physician characteristics also influence deprescribing practices. Further exploration of factors influencing deprescribing patterns, and patient outcomes, is needed.
Authors: Sydney P Springer; Maria K Mor; Florentina Sileanu; Xinhua Zhao; Sherrie L Aspinall; Mary Ersek; Joshua D Niznik; Joseph T Hanlon; Jacob Hunnicutt; Walid F Gellad; Loren J Schleiden; Joshua M Thorpe; Carolyn T Thorpe Journal: J Am Geriatr Soc Date: 2020-02-13 Impact factor: 5.562
Authors: Amanda J Cross; Johnson George; Michael C Woodward; David Ames; Henry Brodaty; Jenni Ilomäki; Rohan A Elliott Journal: Drugs Aging Date: 2016-01 Impact factor: 3.923
Authors: Patrick M Zueger; Holly M Holmes; Gregory S Calip; Dima M Qato; A Simon Pickard; Todd A Lee Journal: J Gen Intern Med Date: 2019-07-25 Impact factor: 6.473
Authors: Wendy Moyle; Najwan El Saifi; Brian Draper; Cindy Jones; Elizabeth Beattie; David Shum; Lukman Thalib; Cindy Mervin; Siobhan O Dwyer Journal: Curr Drug Saf Date: 2017-02-09
Authors: Kim Notenboom; Herman Vromans; Maarten Schipper; Hubert G M Leufkens; Marcel L Bouvy Journal: Front Pharmacol Date: 2016-07-26 Impact factor: 5.810